Search
for
Sort by
Research 30 of 523
- Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C.
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Concomitant Vitiligo and Psoriasis in a Patient Treated with Interferon Alfa‐2a for Chronic Hepatitis B Infection
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection
- Alopesi areata hastalarında serum interferon-gama, tümör nekrozis faktör-alfa, interlökin-13, interlökin-17 ve transforming growth faktör-beta düzeylerinin değerlendirilmesi
- Interferon in the treatment of cutaneous T-cell lymphoma
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- High dose interferon treatment in chronic hepatitis C.
- Segmental Vitiligo and Hair Curling After Interferon α and Ribavirin Treatment for Hepatitis C
- Psoriasis and Hepatitis C: Improvement with Interferon
- Hepatitis C Treatment and Alopecia Totalis
- Reply
- Medication-induced hair loss: An update
- Essential Thrombocythemia: The Dermatologic Point of View
- Clin-Alert
- Aldesleukin
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Telogen Effluvium due to Recombinant Interferon α-2b
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- INTERFERONS IN DERMATOLOGY
- Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin